Alvotech (ALVO)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Alvotech Stock (ALVO) Company Profile

Healthcare (1116)

Prossima data di guadagno

Ultimi documenti SEC

ALVO's Discussions on Twitter

Compare ALVO vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ALVO Alvotech	3.47	1.08B	548.10M	69.50M	-137.90M	0.2303
TAK Takeda Pharmaceutical Co Adr	17.77	56.14B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	115.62	48.81B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.03	44.67B	14.54B	2.22B	2.58B	0.4879
TEVA Teva Pharmaceutical Industries Ltd Adr	28.57	33.27B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	536.12	23.50B	3.18B	1.33B	1.04B	27.90

Alvotech Stock (ALVO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Underweight
2025-11-04	Downgrade	Deutsche Bank	Buy → Hold
2025-10-14	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2025-09-23	Aggiornamento	Deutsche Bank	Hold → Buy
2025-02-14	Iniziato	UBS	Buy
2024-01-29	Aggiornamento	Barclays	Equal Weight → Overweight
2023-10-20	Aggiornamento	Citigroup	Sell → Neutral
2023-09-21	Iniziato	Barclays	Equal Weight
2022-09-07	Iniziato	Morgan Stanley	Equal-Weight
2022-09-06	Downgrade	Citigroup	Buy → Sell
2022-07-26	Iniziato	Citigroup	Buy

Mostra tutto

Alvotech Borsa (ALVO) Ultime notizie

Alvotech Azioni (ALVO) Dati Finanziari

Alvotech (ALVO)

Alvotech Stock (ALVO) Company Profile

Compare ALVO vs TAK, ZTS, HLN, TEVA, UTHR

Alvotech Stock (ALVO) Upgrades & Downgrades

Alvotech Borsa (ALVO) Ultime notizie

Alvotech stock hits 52-week low at 3.65 USD By Investing.com - Investing.com India

Earnings Preview: Alvotech to Report Financial Results Post-market on March 18 - 富途牛牛

Alvotech (NASDAQ: ALVO) investor group reports 33.3% beneficial stake - Stock Titan

Alvotech (NASDAQ:ALVO) Hits New 52-Week LowTime to Sell? - MarketBeat

Alvotech stock hits 52-week low at 3.65 USD - Investing.com Nigeria

Alvotech, Advanz Pharma get EU nod for Eylea biosimilar - MSN

Alvotech files automatic mixed securities shelf - MSN

Alvotech (ALVO) Projected to Post Earnings on Wednesday - MarketBeat

Alvotech (ALVO) Announces Acquisition of Ivers-Lee Group - MSN

Will Alvotech stock attract ESG investorsCPI Data & AI Enhanced Trading Signals - Naître et grandir

Alvotech Stock Plummets to New 52-Week Low of $3.65 - Markets Mojo

ALVO Earnings History & Surprises | EPS & Revenue Results | ALVOTECH SA (NASDAQ:ALVO) - ChartMill

Alvotech to Release Fourth Quarter and Full Year 2025 Financial Results - geneonline.com

Alvotech to Announce Q4 and Full Year 2025 Financial Results on March 18, 2026 - Quiver Quantitative

Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results - The Manila Times

Alvotech schedules March 18 earnings, March 19 investor call - Stock Titan

Alvotech (ALVO) Stock Analysis: Exploring A Potential 375% Upside In The Biosimilar Market - DirectorsTalk Interviews

Alvotech : Managers' transactionsALVOTECH - marketscreener.com

Alvotech stock hits 52-week low at 3.89 USD By Investing.com - Investing.com South Africa

Alvotech’s Biosimilar Bet: Why Wall Street Is Suddenly Watching - AD HOC NEWS

Alvotech (ALVOW) Competitors - Meyka

Alvotech (NASDAQ:ALVO) Sets New 12-Month LowShould You Sell? - MarketBeat

Alvotech stock hits 52-week low at 3.89 USD - Investing.com

Alvotech (NASDAQ:ALVO) Given Average Recommendation of "Reduce" by Analysts - MarketBeat

Alvotech Discloses Intra-Group Transfer of 2.7 Million Shares Within Aztiq Group - TipRanks

Alvotech (NASDAQ: ALVO) discloses 2.7M-share intra-group transfer at $4.74 - Stock Titan

Transactions of Managers and Closely Associated Persons - GlobeNewswire

Alvotech (ALVO) Is Down 9.1% After FDA Rejects AVT05 Over Facility Issues and Legal Probe - simplywall.st

ALVO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alvotech - GlobeNewswire

Alvotech begins European rollout of first-ever Simponi biosimilar Gobivaz - MSN

Alvotech (NASDAQ:ALVO) Cut to Strong Sell at Zacks Research - Defense World

Alvotech (NASDAQ:ALVO) Rating Lowered to Strong Sell at Zacks Research - MarketBeat

Alvotech stock hits 52-week low at $4.31 amid challenging year - Investing.com Australia

Alvotech (NASDAQ:ALVO) Reaches New 1-Year LowHere's Why - MarketBeat

Alvotech (NASDAQ:ALVO) Trading Down 5.7%Here's Why - MarketBeat

Alvotech (ALVO): A 378% Upside Potential In The Biosimilar Market - DirectorsTalk Interviews

Is There Now an Opportunity in Alvotech (ALVO) After a 64% One-Year Share Price Slide? - simplywall.st

Is Alvotech (ALVO) Pricing Make Sense After A 64% One Year Share Price Slump - Yahoo Finance

Alvotech AVT80 Progress And Sandoz Deals Shape Biosimilar Outlook - Yahoo Finance

How Alvotech Equity Warrant stock performs during Fed tightening cyclesEarnings Overview Summary & Free Safe Capital Growth Stock Tips - mfd.ru

Can Alvotech Equity Warrant maintain its current growth rateQuarterly Trade Summary & Accurate Entry and Exit Point Alerts - mfd.ru

Alvotech (ALVO) Announces Strong Results for Clinical Trial for AVT80 - Finviz

Can Alvotech be recession proofJuly 2025 EndofMonth & Weekly Watchlist for Consistent Profits - mfd.ru

12 Best Penny Stocks That Will Skyrocket - Insider Monkey

Is Alvotech the Next Big Biotech Rocket or Just Hype? Real Talk on This Viral Underdog Stock - AD HOC NEWS

How Alvotech (ALVO) Affects Rotational Strategy Timing - Stock Traders Daily

Alvotech’s AVT03 Biosimilar Gains European Approval - MSN

Alvotech resolves global patent disputes with Regeneron and Bayer over Eylea biosimilar - MSN

Assessing Alvotech (ALVO) Valuation After AVT80 Trial Success And New Sandoz Agreements - simplywall.st

Alvotech Azioni (ALVO) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a ALVO